News | May 18, 2025
Indraprastha Medical Corporation posts Q4 FY25 PAT at Rs. 41.01 Cr
Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025
Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025
The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
The publication serves as a foundational tool for identifying gaps and addressing needs in various areas, including rural, urban, and tribal regions
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
Subscribe To Our Newsletter & Stay Updated
